Literature DB >> 16436490

Risk factors for dysbaric osteonecrosis.

K Miyanishi1, Y Kamo, H Ihara, T Naka, M Hirakawa, Y Sugioka.   

Abstract

OBJECTIVES: Dysbaric osteonecrosis (DON) is a complication of ineffective decompression following exposure to high-pressure environments. This study was designed to determine risk factors for the occurrence of DON in divers.
METHODS: Fifty-six male divers received skeletal examinations by radiography to assess the occurrence of DON. A questionnaire was used to obtain clinical and diving information, including diving experience and maximum diving depth. Blood samples were collected to analyse the levels of plasminogen activator inhibitor (PAI)-1, cholesterol, triglyceride, low-density lipoprotein, very low-density lipoprotein, high-density lipoprotein, apolipoprotein A1 and apolipoprotein B.
RESULTS: Lesions of DON were detected in 31 of the 56 (55%) divers. Multivariate logistic regression analysis showed that high levels of PAI-1, a coagulation marker (odds ratio 4.281; P=0.0296) and great maximum diving depth (odds ratio 5.627; P=0.0231) were independent predictors of DON.
CONCLUSIONS: This study has shown the presence of coagulation abnormality in divers with DON. This result suggests that a pharmacological approach incorporating the use of an anticoagulant may represent a potential strategy for the prevention of DON.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436490     DOI: 10.1093/rheumatology/kel013

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

Review 1.  Frequency of decompression illness among recent and extinct mammals and "reptiles": a review.

Authors:  Agnete Weinreich Carlsen
Journal:  Naturwissenschaften       Date:  2017-06-27

Review 2.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

3.  Utility of magnetic resonance spectroscopy and diffusion-weighted imaging for detecting changes in the femoral head in divers with hip pain at risk for dysbaric osteonecrosis.

Authors:  Tsung-Tai Lin; Cheng-Chuan Hu; Yi-Chih Hsu; Chih-Chien Wang; Shih-Wei Chiang; Chao-Ying Wang; Wei-Chou Chang; Guo-Shu Huang
Journal:  Quant Imaging Med Surg       Date:  2022-01

4.  Dysbaric osteonecrosis in diving fisherman: a case report.

Authors:  Seher Kurtul; Nejdiye Güngördü
Journal:  Med Lav       Date:  2022-08-25       Impact factor: 2.244

5.  Dysbaric osteonecrosis in technical divers: The new 'at-risk' group?

Authors:  Brendan Coleman; F Michael Davis
Journal:  Diving Hyperb Med       Date:  2020-09-30       Impact factor: 0.887

6.  Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes.

Authors:  Kazutaka Sakamoto; Makoto Osaki; Akira Hozumi; Hisataka Goto; Tatsuya Fukushima; Hideo Baba; Hiroyuki Shindo
Journal:  BMC Musculoskelet Disord       Date:  2011-04-27       Impact factor: 2.362

7.  Occupational health issues in marine and freshwater research.

Authors:  Glenn Courtenay; Derek R Smith; William Gladstone
Journal:  J Occup Med Toxicol       Date:  2012-03-19       Impact factor: 2.646

8.  Evaluating PAI-1 as a biomarker for stress in diving: human serum total PAI-1 is unaltered after 2 h dry exposures to 280 kPa hyperbaric air.

Authors:  Ingrid Eftedal; Hallvard Aglen Fredriksen; Astrid Hjelde; Andreas Møllerløkken
Journal:  Physiol Rep       Date:  2015-06

9.  Dysbaric osteonecrosis of the humeral head in a patient with type 2 decompressive sickness.

Authors:  Lin Cheng; Pedro Silva; Raef Dahab
Journal:  Spinal Cord Ser Cases       Date:  2021-07-21

10.  Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation.

Authors:  Chiara Chiellini; Olivia Cochet; Luc Negroni; Michel Samson; Marjorie Poggi; Gérard Ailhaud; Marie-Christine Alessi; Christian Dani; Ez-Zoubir Amri
Journal:  BMC Mol Biol       Date:  2008-02-26       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.